Khakoo, S.; Petrillo, A.; Salati, M.; Muhith, A.; Evangelista, J.; Seghezzi, S.; Petrelli, F.; Tomasello, G.; Ghidini, M.
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? Cancers 2021, 13, 4396.
https://doi.org/10.3390/cancers13174396
AMA Style
Khakoo S, Petrillo A, Salati M, Muhith A, Evangelista J, Seghezzi S, Petrelli F, Tomasello G, Ghidini M.
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? Cancers. 2021; 13(17):4396.
https://doi.org/10.3390/cancers13174396
Chicago/Turabian Style
Khakoo, Shelize, Angelica Petrillo, Massimiliano Salati, Abdul Muhith, Jessica Evangelista, Silvia Seghezzi, Fausto Petrelli, Gianluca Tomasello, and Michele Ghidini.
2021. "Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?" Cancers 13, no. 17: 4396.
https://doi.org/10.3390/cancers13174396
APA Style
Khakoo, S., Petrillo, A., Salati, M., Muhith, A., Evangelista, J., Seghezzi, S., Petrelli, F., Tomasello, G., & Ghidini, M.
(2021). Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? Cancers, 13(17), 4396.
https://doi.org/10.3390/cancers13174396
